Global Neoantigen Targeted Therapies Market Insights and Forecast to 2028

Report ID: 1640814 | Published Date: Oct 2024 | No. of Page: 90 | Base Year: 2023 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Neoantigen Targeted Therapies Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Monotherapy
        1.2.3 Combination Therapy
    1.3 Market by Application
        1.3.1 Global Neoantigen Targeted Therapies Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Medical Research Institution
        1.3.3 Hospital and Clinic
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Neoantigen Targeted Therapies Market Perspective (2017-2028)
    2.2 Neoantigen Targeted Therapies Growth Trends by Region
        2.2.1 Neoantigen Targeted Therapies Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Neoantigen Targeted Therapies Historic Market Size by Region (2017-2022)
        2.2.3 Neoantigen Targeted Therapies Forecasted Market Size by Region (2023-2028)
    2.3 Neoantigen Targeted Therapies Market Dynamics
        2.3.1 Neoantigen Targeted Therapies Industry Trends
        2.3.2 Neoantigen Targeted Therapies Market Drivers
        2.3.3 Neoantigen Targeted Therapies Market Challenges
        2.3.4 Neoantigen Targeted Therapies Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Neoantigen Targeted Therapies Players by Revenue
        3.1.1 Global Top Neoantigen Targeted Therapies Players by Revenue (2017-2022)
        3.1.2 Global Neoantigen Targeted Therapies Revenue Market Share by Players (2017-2022)
    3.2 Global Neoantigen Targeted Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Neoantigen Targeted Therapies Revenue
    3.4 Global Neoantigen Targeted Therapies Market Concentration Ratio
        3.4.1 Global Neoantigen Targeted Therapies Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Neoantigen Targeted Therapies Revenue in 2021
    3.5 Neoantigen Targeted Therapies Key Players Head office and Area Served
    3.6 Key Players Neoantigen Targeted Therapies Product Solution and Service
    3.7 Date of Enter into Neoantigen Targeted Therapies Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Neoantigen Targeted Therapies Breakdown Data by Type
    4.1 Global Neoantigen Targeted Therapies Historic Market Size by Type (2017-2022)
    4.2 Global Neoantigen Targeted Therapies Forecasted Market Size by Type (2023-2028)
5 Neoantigen Targeted Therapies Breakdown Data by Application
    5.1 Global Neoantigen Targeted Therapies Historic Market Size by Application (2017-2022)
    5.2 Global Neoantigen Targeted Therapies Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Neoantigen Targeted Therapies Market Size (2017-2028)
    6.2 North America Neoantigen Targeted Therapies Market Size by Type
        6.2.1 North America Neoantigen Targeted Therapies Market Size by Type (2017-2022)
        6.2.2 North America Neoantigen Targeted Therapies Market Size by Type (2023-2028)
        6.2.3 North America Neoantigen Targeted Therapies Market Share by Type (2017-2028)
    6.3 North America Neoantigen Targeted Therapies Market Size by Application
        6.3.1 North America Neoantigen Targeted Therapies Market Size by Application (2017-2022)
        6.3.2 North America Neoantigen Targeted Therapies Market Size by Application (2023-2028)
        6.3.3 North America Neoantigen Targeted Therapies Market Share by Application (2017-2028)
    6.4 North America Neoantigen Targeted Therapies Market Size by Country
        6.4.1 North America Neoantigen Targeted Therapies Market Size by Country (2017-2022)
        6.4.2 North America Neoantigen Targeted Therapies Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Neoantigen Targeted Therapies Market Size (2017-2028)
    7.2 Europe Neoantigen Targeted Therapies Market Size by Type
        7.2.1 Europe Neoantigen Targeted Therapies Market Size by Type (2017-2022)
        7.2.2 Europe Neoantigen Targeted Therapies Market Size by Type (2023-2028)
        7.2.3 Europe Neoantigen Targeted Therapies Market Share by Type (2017-2028)
    7.3 Europe Neoantigen Targeted Therapies Market Size by Application
        7.3.1 Europe Neoantigen Targeted Therapies Market Size by Application (2017-2022)
        7.3.2 Europe Neoantigen Targeted Therapies Market Size by Application (2023-2028)
        7.3.3 Europe Neoantigen Targeted Therapies Market Share by Application (2017-2028)
    7.4 Europe Neoantigen Targeted Therapies Market Size by Country
        7.4.1 Europe Neoantigen Targeted Therapies Market Size by Country (2017-2022)
        7.4.2 Europe Neoantigen Targeted Therapies Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Neoantigen Targeted Therapies Market Size (2017-2028)
    8.2 Asia-Pacific Neoantigen Targeted Therapies Market Size by Type
        8.2.1 Asia-Pacific Neoantigen Targeted Therapies Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Neoantigen Targeted Therapies Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Neoantigen Targeted Therapies Market Share by Type (2017-2028)
    8.3 Asia-Pacific Neoantigen Targeted Therapies Market Size by Application
        8.3.1 Asia-Pacific Neoantigen Targeted Therapies Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Neoantigen Targeted Therapies Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Neoantigen Targeted Therapies Market Share by Application (2017-2028)
    8.4 Asia-Pacific Neoantigen Targeted Therapies Market Size by Region
        8.4.1 Asia-Pacific Neoantigen Targeted Therapies Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Neoantigen Targeted Therapies Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Neoantigen Targeted Therapies Market Size (2017-2028)
    9.2 Latin America Neoantigen Targeted Therapies Market Size by Type
        9.2.1 Latin America Neoantigen Targeted Therapies Market Size by Type (2017-2022)
        9.2.2 Latin America Neoantigen Targeted Therapies Market Size by Type (2023-2028)
        9.2.3 Latin America Neoantigen Targeted Therapies Market Share by Type (2017-2028)
    9.3 Latin America Neoantigen Targeted Therapies Market Size by Application
        9.3.1 Latin America Neoantigen Targeted Therapies Market Size by Application (2017-2022)
        9.3.2 Latin America Neoantigen Targeted Therapies Market Size by Application (2023-2028)
        9.3.3 Latin America Neoantigen Targeted Therapies Market Share by Application (2017-2028)
    9.4 Latin America Neoantigen Targeted Therapies Market Size by Country
        9.4.1 Latin America Neoantigen Targeted Therapies Market Size by Country (2017-2022)
        9.4.2 Latin America Neoantigen Targeted Therapies Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Neoantigen Targeted Therapies Market Size (2017-2028)
    10.2 Middle East & Africa Neoantigen Targeted Therapies Market Size by Type
        10.2.1 Middle East & Africa Neoantigen Targeted Therapies Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Neoantigen Targeted Therapies Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Neoantigen Targeted Therapies Market Share by Type (2017-2028)
    10.3 Middle East & Africa Neoantigen Targeted Therapies Market Size by Application
        10.3.1 Middle East & Africa Neoantigen Targeted Therapies Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Neoantigen Targeted Therapies Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Neoantigen Targeted Therapies Market Share by Application (2017-2028)
    10.4 Middle East & Africa Neoantigen Targeted Therapies Market Size by Country
        10.4.1 Middle East & Africa Neoantigen Targeted Therapies Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Neoantigen Targeted Therapies Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Bavarian Nordic
        11.1.1 Bavarian Nordic Company Details
        11.1.2 Bavarian Nordic Business Overview
        11.1.3 Bavarian Nordic Neoantigen Targeted Therapies Introduction
        11.1.4 Bavarian Nordic Revenue in Neoantigen Targeted Therapies Business (2017-2022)
        11.1.5 Bavarian Nordic Recent Developments
    11.2 Genocea Biosciences
        11.2.1 Genocea Biosciences Company Details
        11.2.2 Genocea Biosciences Business Overview
        11.2.3 Genocea Biosciences Neoantigen Targeted Therapies Introduction
        11.2.4 Genocea Biosciences Revenue in Neoantigen Targeted Therapies Business (2017-2022)
        11.2.5 Genocea Biosciences Recent Developments
    11.3 Gradalis
        11.3.1 Gradalis Company Details
        11.3.2 Gradalis Business Overview
        11.3.3 Gradalis Neoantigen Targeted Therapies Introduction
        11.3.4 Gradalis Revenue in Neoantigen Targeted Therapies Business (2017-2022)
        11.3.5 Gradalis Recent Developments
    11.4 Immunicum
        11.4.1 Immunicum Company Details
        11.4.2 Immunicum Business Overview
        11.4.3 Immunicum Neoantigen Targeted Therapies Introduction
        11.4.4 Immunicum Revenue in Neoantigen Targeted Therapies Business (2017-2022)
        11.4.5 Immunicum Recent Developments
    11.5 Immunovative Therapies
        11.5.1 Immunovative Therapies Company Details
        11.5.2 Immunovative Therapies Business Overview
        11.5.3 Immunovative Therapies Neoantigen Targeted Therapies Introduction
        11.5.4 Immunovative Therapies Revenue in Neoantigen Targeted Therapies Business (2017-2022)
        11.5.5 Immunovative Therapies Recent Developments
    11.6 Iovance Biotherapeutics
        11.6.1 Iovance Biotherapeutics Company Details
        11.6.2 Iovance Biotherapeutics Business Overview
        11.6.3 Iovance Biotherapeutics Neoantigen Targeted Therapies Introduction
        11.6.4 Iovance Biotherapeutics Revenue in Neoantigen Targeted Therapies Business (2017-2022)
        11.6.5 Iovance Biotherapeutics Recent Developments
    11.7 MediGene
        11.7.1 MediGene Company Details
        11.7.2 MediGene Business Overview
        11.7.3 MediGene Neoantigen Targeted Therapies Introduction
        11.7.4 MediGene Revenue in Neoantigen Targeted Therapies Business (2017-2022)
        11.7.5 MediGene Recent Developments
    11.8 Neon Therapeutics
        11.8.1 Neon Therapeutics Company Details
        11.8.2 Neon Therapeutics Business Overview
        11.8.3 Neon Therapeutics Neoantigen Targeted Therapies Introduction
        11.8.4 Neon Therapeutics Revenue in Neoantigen Targeted Therapies Business (2017-2022)
        11.8.5 Neon Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Neoantigen Targeted Therapies Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Monotherapy
    Table 3. Key Players of Combination Therapy
    Table 4. Global Neoantigen Targeted Therapies Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Neoantigen Targeted Therapies Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Neoantigen Targeted Therapies Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Neoantigen Targeted Therapies Market Share by Region (2017-2022)
    Table 8. Global Neoantigen Targeted Therapies Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Neoantigen Targeted Therapies Market Share by Region (2023-2028)
    Table 10. Neoantigen Targeted Therapies Market Trends
    Table 11. Neoantigen Targeted Therapies Market Drivers
    Table 12. Neoantigen Targeted Therapies Market Challenges
    Table 13. Neoantigen Targeted Therapies Market Restraints
    Table 14. Global Neoantigen Targeted Therapies Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Neoantigen Targeted Therapies Revenue Share by Players (2017-2022)
    Table 16. Global Top Neoantigen Targeted Therapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neoantigen Targeted Therapies as of 2021)
    Table 17. Ranking of Global Top Neoantigen Targeted Therapies Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Neoantigen Targeted Therapies Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Neoantigen Targeted Therapies Product Solution and Service
    Table 21. Date of Enter into Neoantigen Targeted Therapies Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Neoantigen Targeted Therapies Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Neoantigen Targeted Therapies Revenue Market Share by Type (2017-2022)
    Table 25. Global Neoantigen Targeted Therapies Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Neoantigen Targeted Therapies Revenue Market Share by Type (2023-2028)
    Table 27. Global Neoantigen Targeted Therapies Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Neoantigen Targeted Therapies Revenue Share by Application (2017-2022)
    Table 29. Global Neoantigen Targeted Therapies Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Neoantigen Targeted Therapies Revenue Share by Application (2023-2028)
    Table 31. North America Neoantigen Targeted Therapies Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Neoantigen Targeted Therapies Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Neoantigen Targeted Therapies Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Neoantigen Targeted Therapies Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Neoantigen Targeted Therapies Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Neoantigen Targeted Therapies Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Neoantigen Targeted Therapies Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Neoantigen Targeted Therapies Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Neoantigen Targeted Therapies Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Neoantigen Targeted Therapies Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Neoantigen Targeted Therapies Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Neoantigen Targeted Therapies Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Neoantigen Targeted Therapies Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Neoantigen Targeted Therapies Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Neoantigen Targeted Therapies Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Neoantigen Targeted Therapies Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Neoantigen Targeted Therapies Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Neoantigen Targeted Therapies Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Neoantigen Targeted Therapies Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Neoantigen Targeted Therapies Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Neoantigen Targeted Therapies Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Neoantigen Targeted Therapies Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Neoantigen Targeted Therapies Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Neoantigen Targeted Therapies Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Neoantigen Targeted Therapies Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Neoantigen Targeted Therapies Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Neoantigen Targeted Therapies Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Neoantigen Targeted Therapies Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Neoantigen Targeted Therapies Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Neoantigen Targeted Therapies Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Bavarian Nordic Company Details
    Table 62. Bavarian Nordic Business Overview
    Table 63. Bavarian Nordic Neoantigen Targeted Therapies Product
    Table 64. Bavarian Nordic Revenue in Neoantigen Targeted Therapies Business (2017-2022) & (US$ Million)
    Table 65. Bavarian Nordic Recent Developments
    Table 66. Genocea Biosciences Company Details
    Table 67. Genocea Biosciences Business Overview
    Table 68. Genocea Biosciences Neoantigen Targeted Therapies Product
    Table 69. Genocea Biosciences Revenue in Neoantigen Targeted Therapies Business (2017-2022) & (US$ Million)
    Table 70. Genocea Biosciences Recent Developments
    Table 71. Gradalis Company Details
    Table 72. Gradalis Business Overview
    Table 73. Gradalis Neoantigen Targeted Therapies Product
    Table 74. Gradalis Revenue in Neoantigen Targeted Therapies Business (2017-2022) & (US$ Million)
    Table 75. Gradalis Recent Developments
    Table 76. Immunicum Company Details
    Table 77. Immunicum Business Overview
    Table 78. Immunicum Neoantigen Targeted Therapies Product
    Table 79. Immunicum Revenue in Neoantigen Targeted Therapies Business (2017-2022) & (US$ Million)
    Table 80. Immunicum Recent Developments
    Table 81. Immunovative Therapies Company Details
    Table 82. Immunovative Therapies Business Overview
    Table 83. Immunovative Therapies Neoantigen Targeted Therapies Product
    Table 84. Immunovative Therapies Revenue in Neoantigen Targeted Therapies Business (2017-2022) & (US$ Million)
    Table 85. Immunovative Therapies Recent Developments
    Table 86. Iovance Biotherapeutics Company Details
    Table 87. Iovance Biotherapeutics Business Overview
    Table 88. Iovance Biotherapeutics Neoantigen Targeted Therapies Product
    Table 89. Iovance Biotherapeutics Revenue in Neoantigen Targeted Therapies Business (2017-2022) & (US$ Million)
    Table 90. Iovance Biotherapeutics Recent Developments
    Table 91. MediGene Company Details
    Table 92. MediGene Business Overview
    Table 93. MediGene Neoantigen Targeted Therapies Product
    Table 94. MediGene Revenue in Neoantigen Targeted Therapies Business (2017-2022) & (US$ Million)
    Table 95. MediGene Recent Developments
    Table 96. Neon Therapeutics Company Details
    Table 97. Neon Therapeutics Business Overview
    Table 98. Neon Therapeutics Neoantigen Targeted Therapies Product
    Table 99. Neon Therapeutics Revenue in Neoantigen Targeted Therapies Business (2017-2022) & (US$ Million)
    Table 100. Neon Therapeutics Recent Developments
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neoantigen Targeted Therapies Market Share by Type: 2021 VS 2028
    Figure 2. Monotherapy Features
    Figure 3. Combination Therapy Features
    Figure 4. Global Neoantigen Targeted Therapies Market Share by Application: 2021 VS 2028
    Figure 5. Medical Research Institution Case Studies
    Figure 6. Hospital and Clinic Case Studies
    Figure 7. Other Case Studies
    Figure 8. Neoantigen Targeted Therapies Report Years Considered
    Figure 9. Global Neoantigen Targeted Therapies Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Neoantigen Targeted Therapies Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Neoantigen Targeted Therapies Market Share by Region: 2021 VS 2028
    Figure 12. Global Neoantigen Targeted Therapies Market Share by Players in 2021
    Figure 13. Global Top Neoantigen Targeted Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neoantigen Targeted Therapies as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Neoantigen Targeted Therapies Revenue in 2021
    Figure 15. North America Neoantigen Targeted Therapies Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Neoantigen Targeted Therapies Market Size Market Share by Type (2017-2028)
    Figure 17. North America Neoantigen Targeted Therapies Market Size Market Share by Application (2017-2028)
    Figure 18. North America Neoantigen Targeted Therapies Market Size Share by Country (2017-2028)
    Figure 19. United States Neoantigen Targeted Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Neoantigen Targeted Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Neoantigen Targeted Therapies Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Neoantigen Targeted Therapies Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Neoantigen Targeted Therapies Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Neoantigen Targeted Therapies Market Size Share by Country (2017-2028)
    Figure 25. Germany Neoantigen Targeted Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Neoantigen Targeted Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Neoantigen Targeted Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Neoantigen Targeted Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Neoantigen Targeted Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Neoantigen Targeted Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Neoantigen Targeted Therapies Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Neoantigen Targeted Therapies Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Neoantigen Targeted Therapies Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Neoantigen Targeted Therapies Market Size Share by Region (2017-2028)
    Figure 35. China Neoantigen Targeted Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Neoantigen Targeted Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Neoantigen Targeted Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Neoantigen Targeted Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Neoantigen Targeted Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Neoantigen Targeted Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Neoantigen Targeted Therapies Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Neoantigen Targeted Therapies Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Neoantigen Targeted Therapies Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Neoantigen Targeted Therapies Market Size Share by Country (2017-2028)
    Figure 45. Mexico Neoantigen Targeted Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Neoantigen Targeted Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Neoantigen Targeted Therapies Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Neoantigen Targeted Therapies Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Neoantigen Targeted Therapies Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Neoantigen Targeted Therapies Market Size Share by Country (2017-2028)
    Figure 51. Turkey Neoantigen Targeted Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Neoantigen Targeted Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Neoantigen Targeted Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Bavarian Nordic Revenue Growth Rate in Neoantigen Targeted Therapies Business (2017-2022)
    Figure 55. Genocea Biosciences Revenue Growth Rate in Neoantigen Targeted Therapies Business (2017-2022)
    Figure 56. Gradalis Revenue Growth Rate in Neoantigen Targeted Therapies Business (2017-2022)
    Figure 57. Immunicum Revenue Growth Rate in Neoantigen Targeted Therapies Business (2017-2022)
    Figure 58. Immunovative Therapies Revenue Growth Rate in Neoantigen Targeted Therapies Business (2017-2022)
    Figure 59. Iovance Biotherapeutics Revenue Growth Rate in Neoantigen Targeted Therapies Business (2017-2022)
    Figure 60. MediGene Revenue Growth Rate in Neoantigen Targeted Therapies Business (2017-2022)
    Figure 61. Neon Therapeutics Revenue Growth Rate in Neoantigen Targeted Therapies Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bavarian Nordic
Genocea Biosciences
Gradalis
Immunicum
Immunovative Therapies
Iovance Biotherapeutics
MediGene
Neon Therapeutics
Frequently Asked Questions
Neoantigen Targeted Therapies report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neoantigen Targeted Therapies report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neoantigen Targeted Therapies report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports